(Q54605466)

English

Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

0 references

autosomal dominant polycystic kidney disease

0 references

autosomal dominant polycystic kidney

1 reference

based on heuristic

inferred from title

author name string

E Meijer

1

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

R T Gansevoort

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

P E de Jong

3

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

A M van der Wal

4

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

W N Leonhard

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

S R de Krey

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

J van den Born

7

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

G M Mulder

8

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

H van Goor

9

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

J Struck

10

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

E de Heer

11

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

D J M Peters

12

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

language of work or name

0 references

publication date

10 March 2011

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

26

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

2445-2453

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

8

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

Autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Vasopressin directly regulates cyst growth in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Evidence of extraordinary growth in the progressive enlargement of renal cysts

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

The tandem endocytic receptors megalin and cubilin are important proteins in renal pathology.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Axial heterogeneity of vasopressin-receptor subtypes along the human and mouse collecting duct.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Copeptin: clinical use of a new biomarker

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Sirolimus therapy to halt the progression of ADPKD.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR069

21 January 2018

Identifiers

10.1093/NDT/GFR069

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21393612

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54605466&oldid=1516844195"